Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

19.90
Delayed Data
As of Dec 02
 +0.47 / +2.42%
Today’s Change
13.05
Today|||52-Week Range
23.44
-8.17%
Year-to-Date
Top Research Reports for 29th November, 2016
Nov 29 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close19.43
Today’s open19.52
Day’s range19.29 - 20.35
Volume2,191,768
Average volume (3 months)3,545,934
Market cap$3.2B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+3.92%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+154.94%
P/E ratioNM
Price/Sales4.46
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.67+2.53%
CBPOChina Biologic Produ...+1.21+1.07%
RAREUltragenyx Pharmaceu...-0.14-0.19%
CTLTCatalent Inc+0.52+2.25%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$757.0M
Annual profit (last year)$39.5M
Net profit margin5.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
Chief Operating Officer &
Executive Vice President
Barry J. Moze
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs